Liz Hockley

Key details

.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 225

Articles by Liz Hockley

Ricoh strengthens US unit with CRISPR gene editing licence
CRISPR
Japanese imaging and electronics firm has acquired non-exclusive licence from ERS Genomics | Technology will be used by Elixirgen Scientific, acquired by Ricoh in 2022.   14 March 2024
Ozempic counterfeits prompt Novo Nordisk to join forces with authorities
Pharma
Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.   12 March 2024
Extension of COVID-19 vaccine waiver uncertain after WTO conference
Pharma
WTO members failed to reach consensus on whether to expand patent waiver agreed in 2022 | Extended proposal would include tests and treatments for COVID-19.   7 March 2024
Careers
‘Creative litigation strategist’ will expand firm’s capacity in complex technology areas | New hire joins from LTL Attorneys and spent much of career at Quinn Emanuel.   7 March 2024
MedTech
US medical device company alleges Catalyst Orthoscience infringed patent through reverse shoulder surgery system | Firm seeks to enforce a patent granted in October last year.   29 February 2024
Pharma
Firm wishes to avoid ‘protracted litigation’ with confidential settlement | Counsel for GSK told Delaware judge in January that lawsuits are ‘way ahead of the science’.   29 February 2024
Careers
Partner with extensive patent litigation experience joins London office | A&O is finalising merger with Shearman & Sterling.   28 February 2024
Biotech
UPC overturns previous decision barring NanoString from selling CosMx products in 17 European countries | Court did not stay proceedings on account of NanoString’s Chapter 11 filing.   27 February 2024
Pharma
Board determines that Nevro added subject matter to patent through amendment | Medtronic and Boston Scientific have successfully overturned 2019 decision rejecting opposition.   20 February 2024
Pharma
US pharma firm has not admitted liability as part of agreement with Lipitor buyers following a long-running dispute over a cholesterol drug | Litigation against Sun Pharma’s Ranbaxy will continue.   15 February 2024

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.